0001209191-22-037521.txt : 20220616 0001209191-22-037521.hdr.sgml : 20220616 20220616171219 ACCESSION NUMBER: 0001209191-22-037521 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220615 FILED AS OF DATE: 20220616 DATE AS OF CHANGE: 20220616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Makara Richard CENTRAL INDEX KEY: 0001798130 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36279 FILM NUMBER: 221021444 MAIL ADDRESS: STREET 1: C/O CARA THERAPEUTICS, INC. STREET 2: 4 STAMFORD PLAZA, 107 ELM STREET, 9TH FL CITY: STAMDFORD STATE: CT ZIP: 06902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cara Therapeutics, Inc. CENTRAL INDEX KEY: 0001346830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4 STAMFORD PLAZA STREET 2: 107 ELM STREET 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-406-3700 MAIL ADDRESS: STREET 1: 4 STAMFORD PLAZA STREET 2: 107 ELM STREET 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 FORMER COMPANY: FORMER CONFORMED NAME: Cara Therapeutics Inc DATE OF NAME CHANGE: 20051213 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2022-06-15 0 0001346830 Cara Therapeutics, Inc. CARA 0001798130 Makara Richard C/O CARA THERAPEUTICS, INC. 107 ELM STREET, 4 STAMFORD PLAZA STAMFORD CT 06902 0 1 0 0 VP, Head of Accting;Controller Common Stock 6083 D Stock Option (Right to Buy) 17.41 2027-03-08 Common Stock 20000 D Stock Option (Right to Buy) 13.51 2027-08-17 Common Stock 20000 D Stock Option (Right to Buy) 14.18 2028-03-06 Common Stock 20000 D Stock Option (Right to Buy) 16.10 2029-03-06 Common Stock 30000 D Stock Option (Right to Buy) 16.36 2030-02-24 Common Stock 30000 D Stock Option (Right to Buy) 18.93 2031-03-03 Common Stock 30000 D Stock Option (Right to Buy) 10.46 2032-02-25 Common Stock 20000 D Includes 5,083 shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. (1) 50% of the RSUs will vest on December 15, 2022; and (2) the remaining 50% of the RSUs will vest on June 15,2023, subject to the Reporting Person's continued service to the Issuer on each such date. Fully vested and immediately exercisable. The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on April 6, 2019, subject to the Reporting Person's continuous service with the Issuer as of each such date. The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on March 24, 2020, subject to the Reporting Person's continuous service with the Issuer as of each such date. The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on April 3, 2021, subject to the Reporting Person's continuous service with the Issuer as of each such date. The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on March 25, 2022, subject to the Reporting Person's continuous service with the Issuer as of each such date. Exhibit List - Exhibit 24 - Power of Attorney /s/ Darren DeStefano, Attorney-in-Fact 2022-06-16 EX-24 2 poa.txt POA DOCUMENT POWER OF ATTORNEY (For Executing Form ID and Forms 3, 4 and 5) Know all by these presents that the undersigned hereby constitutes and appoints each of Darren DeStefano, Jenny Park O'Shanick, Tommi McCarthy and Jordan B. Verrilli of Cooley LLP and Christopher Posner and Scott Terrillion of Cara Therapeutics, Inc., signing individually, the undersigned's true and lawful attorney-in-fact and agents to: (1) Prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the Securities and Exchange Commission a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the Securities and Exchange Commission of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation thereunder; (2) Prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the Securities and Exchange Commission Forms 3, 4 and 5 (including amendments thereto and joint filing agreements in connection therewith) in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (3) Do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to prepare and execute any such Form 3, 4 or 5 (including amendments thereto and joint filing agreements in connection therewith) and file such forms with the Securities and Exchange Commission and any stock exchange, self-regulatory association or any other authority; and (4) Take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required of the undersigned, it being understood that the documents executed by the attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as the attorney-in-fact may approve in the attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in- fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, and their substitutes, in serving in such capacity at the request of the undersigned, are not assuming (nor is Cara Therapeutics, Inc. assuming) any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by Cara Therapeutics, Inc., unless earlier revoked by the undersigned in a signed writing delivered to Cara Therapeutics, Inc. and the attorneys-in-fact. This Power of Attorney revokes any other power of attorney that the undersigned has previously granted to representatives of the Cara Therapeutics, Inc. and Cooley LLP. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date written below. Dated: June 7, 2022 By: /s/ Richard Makara Name: Richard Makara